PATHOGENESIS AND MODERN THERAPEUTIC STRATEGIES IN RHEUMATOID ARTHRITIS
| dc.contributor.author | S. B. Parpieva | |
| dc.contributor.author | E. A.Vasilevsky | |
| dc.contributor.author | O.T.Dadabaev | |
| dc.contributor.author | N. G. Kamalov | |
| dc.date.accessioned | 2025-12-28T15:25:49Z | |
| dc.date.issued | 2025-10-18 | |
| dc.description.abstract | Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease that primarily manifests as a persistent inflammatory synovitis, leading to progressive cartilage damage and bone erosion if left undertreated [6]. Affecting up to 1% of the global population, RA imposes a substantial burden on individuals and healthcare systems, often causing significant pain, functional disability, and a diminished quality of life [6]. The last two decades have witnessed a revolutionary shift in the management of RA. | |
| dc.format | application/pdf | |
| dc.identifier.uri | https://theconferencehub.com/index.php/tch/article/view/568 | |
| dc.identifier.uri | https://asianeducationindex.com/handle/123456789/8906 | |
| dc.language.iso | eng | |
| dc.publisher | The Conference Hub | |
| dc.relation | https://theconferencehub.com/index.php/tch/article/view/568/581 | |
| dc.rights | https://creativecommons.org/licenses/by/4.0 | |
| dc.source | The Conference Hub; 2025: ICHARSE-USA-OCTOBER; 46-49 | |
| dc.title | PATHOGENESIS AND MODERN THERAPEUTIC STRATEGIES IN RHEUMATOID ARTHRITIS | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | Peer-reviewed Article |
item.page.files
item.page.filesection.original.bundle
pagination.showing.detail
loading.default
- item.page.filesection.name
- parpieva_2025_pathogenesis_and_modern_therapeutic_stra.pdf
- item.page.filesection.size
- 300.7 KB
- item.page.filesection.format
- Adobe Portable Document Format